Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 139,229 182,993 316,353 638,922
Total Sell Value $12,316,080 $16,513,389 $28,948,007 $60,375,372
Total People Sold 5 5 6 8
Total Sell Transactions 11 15 24 57
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 1303
  Page 19 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wood Mark VP, Human Resources   •       –      –    2012-07-23 4 AS $39.25 $104,633 D/D (2,666) 32,364     -
   Wood Mark VP, Human Resources   •       –      –    2012-07-23 4 OE $14.39 $54,420 D/D 2,666 35,030     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-07-10 4 AS $42.50 $106,250 D/D (2,500) 15,340     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-07-10 4 OE $14.39 $35,975 D/D 2,500 17,840     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-07-02 4 AS $40.00 $110,800 D/D (2,770) 15,340     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-07-02 4 OE $17.86 $49,472 D/D 2,770 18,110     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-07-02 4 AS $40.00 $3,813,800 D/D (95,345) 59,030     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2012-07-02 4 OE $17.54 $1,672,351 D/D 95,345 154,375     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-07-02 4 AS $40.00 $602,808 D/D (15,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-07-02 4 OE $11.05 $165,750 D/D 15,000 67,277     -
   Wood Mark VP, Human Resources   •       –      –    2012-06-27 4 AS $38.00 $30,856 D/D (812) 32,364     -
   Wood Mark VP, Human Resources   •       –      –    2012-06-27 4 OE $26.49 $21,510 D/D 812 33,176     -
   Wood Mark VP, Human Resources   •       –      –    2012-06-22 4 AS $36.83 $68,245 D/D (1,853) 32,364     -
   Wood Mark VP, Human Resources   •       –      –    2012-06-22 4 OE $14.39 $32,884 D/D 1,853 34,217     -
   Wood Mark VP, Human Resources   •       –      –    2012-06-06 5 D $37.99 $17,437 D/D (459) 22,657     -
   Wood Mark VP, Human Resources   •       –      –    2012-06-06 4 OE $0.00 $0 D/D 1,250 32,364     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-06-01 4 AS $35.02 $175,078 D/D (5,000) 52,277     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2012-06-01 4 OE $11.05 $55,250 D/D 5,000 57,277     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-05-31 5 D $35.64 $10,336 D/D (290) 14,746     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-31 4 OE $6.46 $12,920 D/D 2,000 178,691     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-31 4 OE $6.46 $51,680 D/D 8,000 176,691     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2012-05-29 4 A $0.00 $0 D/D 33,000 33,000     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-05-22 4 D $37.98 $2,127 D/D (56) 15,340     -
   Mueller Brian VP, Corporate Controller   •       –      –    2012-05-22 4 OE $0.00 $0 D/D 150 15,396     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2012-05-16 4 AS $38.47 $577,370 D/D (15,000) 168,691     -
  1303 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 19 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us